全文获取类型
收费全文 | 373024篇 |
免费 | 15429篇 |
国内免费 | 968篇 |
专业分类
耳鼻咽喉 | 5038篇 |
儿科学 | 13190篇 |
妇产科学 | 9643篇 |
基础医学 | 49660篇 |
口腔科学 | 13736篇 |
临床医学 | 28626篇 |
内科学 | 75000篇 |
皮肤病学 | 9188篇 |
神经病学 | 26768篇 |
特种医学 | 15725篇 |
外国民族医学 | 123篇 |
外科学 | 50821篇 |
综合类 | 2819篇 |
现状与发展 | 1篇 |
一般理论 | 72篇 |
预防医学 | 34711篇 |
眼科学 | 7409篇 |
药学 | 24841篇 |
5篇 | |
中国医学 | 1008篇 |
肿瘤学 | 21037篇 |
出版年
2022年 | 2008篇 |
2021年 | 4417篇 |
2020年 | 3006篇 |
2019年 | 4088篇 |
2018年 | 8432篇 |
2017年 | 7509篇 |
2016年 | 6822篇 |
2015年 | 8953篇 |
2014年 | 10015篇 |
2013年 | 10774篇 |
2012年 | 21215篇 |
2011年 | 16979篇 |
2010年 | 8496篇 |
2009年 | 9480篇 |
2008年 | 11687篇 |
2007年 | 12853篇 |
2006年 | 12364篇 |
2005年 | 19992篇 |
2004年 | 20392篇 |
2003年 | 15510篇 |
2002年 | 9501篇 |
2001年 | 9457篇 |
2000年 | 6828篇 |
1999年 | 10218篇 |
1998年 | 2186篇 |
1996年 | 1745篇 |
1992年 | 9480篇 |
1991年 | 9607篇 |
1990年 | 9659篇 |
1989年 | 9240篇 |
1988年 | 8543篇 |
1987年 | 8136篇 |
1986年 | 7743篇 |
1985年 | 6976篇 |
1984年 | 4855篇 |
1983年 | 3926篇 |
1979年 | 4732篇 |
1978年 | 2964篇 |
1977年 | 2273篇 |
1976年 | 1969篇 |
1975年 | 3023篇 |
1974年 | 3642篇 |
1973年 | 3278篇 |
1972年 | 3202篇 |
1971年 | 3145篇 |
1970年 | 3001篇 |
1969年 | 2907篇 |
1968年 | 2680篇 |
1967年 | 2537篇 |
1966年 | 2221篇 |
排序方式: 共有10000条查询结果,搜索用时 703 毫秒
71.
72.
Bj?rn Stessel Audrey A. Fiddelers Elbert A. Joosten Daisy M.N. Hoofwijk Hans-Fritz Gramke Wolfgang F.F.A. Buhre 《Medicine》2015,94(39)
Traditionally, major complications and unanticipated admission/readmission rates were used to assess outcome after day surgery. However, in view of the relative absence of major complications the quality of recovery (QOR) should be considered one of the principal endpoints after day surgery. In our study, the level of QOR is defined by a combination of the Global Surgical Recovery (GSR) Index and the Quality of Life (QOL).The aim of this study was to analyze prevalence and predictors of QOR after day surgery on the fourth postoperative day.Elective patients scheduled for day surgery from November 2008 to April 2010 were enrolled in a prospective cohort study. Outcome parameters were measured by using questionnaire packages at 2 time points: 1 week preoperatively and 4 days postoperatively. Primary outcome parameter is the QOR and is defined as good if the GSR index >80% as well as the postoperative QOL is unchanged or improved as compared with baseline. QOR is defined as poor if both the GSR index ≤80% and if the postoperative QOL is decreased as compared with baseline. QOR is defined as intermediate in all other cases. Three logistic regression analyses were performed to determine predictors for poor QOR after day surgery.A total of 1118 patients were included. A good QOR was noted in 17.3% of patients, an intermediate QOR in 34.8%, and a poor QOR in 47.8% 4 days after day surgery. The best predictor for poor QOR after day surgery was type of surgery. Other predictors were younger age, work status, and longer duration of surgery. A history of previous surgery, expected pain (by the patient) and high long-term surgical fear were significant predictors of poor QOR in only 1 of 3 prediction models.The QOR at home 4 days after day surgery was poor in the majority of patients and showed a significant procedure-specific variation. Patients at risk for poor QOR can be identified during the preoperative period based on type of surgery, age, work status, and the duration of the surgery. 相似文献
73.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
74.
75.
Lara Feulner Hamed S. Najafabadi Simon Tanguay Janusz Rak Yasser Riazalhosseini 《Urologic oncology》2019,37(2):166-175
Background
Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.Methods
Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.Results
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.Conclusion
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment. 相似文献76.
77.
Peffault de Latour Rgis Huynh Lynn Ivanova Jasmina I. Totev Todor Bilginsoy Mehmet Antin Joseph Roy Anuja Duh Mei Sheng 《Annals of hematology》2020,99(4):743-752
Annals of Hematology - This study assessed treatment patterns and healthcare resource utilization (HRU) of patients with severe aplastic anemia (SAA) with insufficient response to immunosuppressive... 相似文献
78.
79.
80.